Update: 27.02.2024
Last week: 7 week 2024 (12.02.2024 - 18.02.2024)
Last full month: January 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 141 | 8.2% | 11.1% | 0.9 | 16 129 992 | 8.5% | 9.6% | 0.8 | -0.2% |
| MoM | 26 944 | -13.8% | 11.2% | 1.1 | 60 190 108 | -9.5% | 9.7% | 1.2 | -22.4% |
| YTD | 44 985 | 26.6% | 11.0% | 2.1 | 100 764 442 | 57.8% | 9.6% | 2 | 2.6% |
| MAT | 350 288 | 33.6% | 9.4% | 1.8 | 693 714 240 | 44.0% | 7.9% | 1.5 | 7.4% |
| BRAINMAX | |||||||||
| WoW | 923 | -5.5% | 100.0% | 0 | 3 355 432 | -6.1% | 100.0% | 0 | -5.5% |
| MoM | 4 282 | -21.7% | 100.0% | 0 | 15 184 484 | -21.8% | 100.0% | 0 | -21.7% |
| YTD | 6 705 | 85.1% | 100.0% | 0 | 23 981 182 | 96.9% | 100.0% | 0 | 85.1% |
| MAT | 49 733 | 260.1% | 100.0% | NA | 172 798 684 | 284.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 17 288 | 6.4% | 43.9% | 0 | 55 329 098 | 7.6% | 35.8% | -0.1 | 6.5% |
| MoM | 67 010 | 7.4% | 43.5% | -2.3 | 219 972 521 | 8.7% | 36.1% | -3.2 | 13.2% |
| YTD | 110 045 | 6.3% | 43.6% | 2.4 | 357 192 497 | 14.6% | 36.0% | -1 | 0.4% |
| MAT | 875 561 | 23.0% | 45.2% | 2.6 | 2 737 072 201 | 31.1% | 39.5% | 2.5 | 15.8% |
| MIGRENIUM | |||||||||
| WoW | 13 627 | 3.8% | 0.6% | 0 | 3 944 889 | 7.3% | 0.7% | 0.1 | -2.6% |
| MoM | 49 774 | 6.2% | 0.5% | 0.1 | 13 094 535 | 21.4% | 0.6% | 0.2 | -12.8% |
| YTD | 84 254 | 2.5% | 0.5% | -0.1 | 22 823 500 | 53.8% | 0.6% | 0.1 | 26.8% |
| MAT | 643 665 | 9.0% | 0.6% | 0 | 130 646 155 | 24.0% | 0.5% | 0 | 8.6% |
| MODELAX-N | |||||||||
| WoW | 31 087 | 2.0% | 22.7% | 0 | 12 789 953 | 4.3% | 14.1% | 0.4 | 1.9% |
| MoM | 119 582 | 21.1% | 20.1% | 3.9 | 47 270 565 | 27.9% | 12.0% | 2.8 | -2.4% |
| YTD | 198 759 | 61.2% | 21.0% | 4.7 | 79 430 663 | 97.8% | 12.7% | 3.1 | 25.5% |
| MAT | 1 243 471 | 156.6% | 19.2% | 10.4 | 422 080 216 | 159.6% | 10.8% | 5.8 | 17.9% |
| REDUXIN | |||||||||
| WoW | 13 045 | 8.4% | 33.1% | 0.6 | 71 245 323 | 9.3% | 46.1% | 0.6 | 6.5% |
| MoM | 52 526 | 24.8% | 34.1% | 3.2 | 284 702 122 | 30.8% | 46.8% | 4.5 | 13.2% |
| YTD | 85 176 | -3.4% | 33.7% | -1.4 | 461 782 391 | 23.4% | 46.5% | 2.2 | 0.4% |
| MAT | 634 812 | 3.1% | 32.8% | -4 | 2 960 772 124 | 13.4% | 42.7% | -3.6 | 15.8% |
| REDUXIN FORTE | |||||||||
| WoW | 3 683 | 6.1% | 9.3% | 0 | 16 651 803 | 5.1% | 10.8% | -0.3 | 6.5% |
| MoM | 12 983 | 5.2% | 8.4% | -0.6 | 56 969 472 | 5.2% | 9.4% | -1.2 | 13.2% |
| YTD | 22 022 | 8.3% | 8.7% | 0.6 | 97 928 928 | 31.6% | 9.9% | 1 | 0.4% |
| MAT | 167 695 | 33.0% | 8.7% | 1.1 | 677 003 490 | 42.2% | 9.8% | 1.3 | 15.8% |
| SALVISAR | |||||||||
| WoW | 8 789 | 3.9% | 1.1% | 0 | 3 299 513 | 8.0% | 1.0% | 0 | 2.5% |
| MoM | 33 814 | -10.9% | 1.0% | 0 | 11 736 943 | -6.1% | 0.8% | 0 | -10.4% |
| YTD | 55 949 | -25.1% | 1.1% | -0.6 | 19 842 533 | -17.5% | 0.9% | -0.5 | 13.3% |
| MAT | 479 680 | -24.0% | 1.2% | -0.4 | 159 543 199 | -25.2% | 1.0% | -0.4 | 3.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 44 985 | 26.6% | 11.0% | 2.1 | 100 764 442 | 57.8% | 9.6% | 2 | 2.6% |
| BRAINMAX | 6 705 | 85.1% | 100.0% | 0 | 23 981 182 | 96.9% | 100.0% | 0 | 85.1% |
| GOLDLINE PLUS | 110 045 | 6.3% | 43.6% | 2.4 | 357 192 497 | 14.6% | 36.0% | -1 | 0.4% |
| MIGRENIUM | 84 254 | 2.5% | 0.5% | -0.1 | 22 823 500 | 53.8% | 0.6% | 0.1 | 26.8% |
| MODELAX-N | 198 759 | 61.2% | 21.0% | 4.7 | 79 430 663 | 97.8% | 12.7% | 3.1 | 25.5% |
| REDUXIN CAPS | 85 176 | -3.4% | 33.7% | -1.4 | 461 782 391 | 23.4% | 46.5% | 2.2 | 0.4% |
| REDUXIN FORTE | 22 022 | 8.3% | 8.7% | 0.6 | 97 928 928 | 31.6% | 9.9% | 1 | 0.4% |
| SALVISAR | 55 949 | -25.1% | 1.1% | -0.6 | 19 842 533 | -17.5% | 0.9% | -0.5 | 13.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 350 288 | 33.6% | 9.4% | 1.8 | 693 714 240 | 44.0% | 7.9% | 1.5 | 7.4% |
| BRAINMAX | 49 733 | 260.1% | 100.0% | NA | 172 798 684 | 284.4% | 100.0% | NA | NA |
| GOLDLINE PLUS | 875 561 | 23.0% | 45.2% | 2.6 | 2 737 072 201 | 31.1% | 39.5% | 2.5 | 15.8% |
| MIGRENIUM | 643 665 | 9.0% | 0.6% | 0 | 130 646 155 | 24.0% | 0.5% | 0 | 8.6% |
| MODELAX-N | 1 243 471 | 156.6% | 19.2% | 10.4 | 422 080 216 | 159.6% | 10.8% | 5.8 | 17.9% |
| REDUXIN CAPS | 634 812 | 3.1% | 32.8% | -4 | 2 960 772 124 | 13.4% | 42.7% | -3.6 | 15.8% |
| REDUXIN FORTE | 167 695 | 33.0% | 8.7% | 1.1 | 677 003 490 | 42.2% | 9.8% | 1.3 | 15.8% |
| SALVISAR | 479 680 | -24.0% | 1.2% | -0.4 | 159 543 199 | -25.2% | 1.0% | -0.4 | 3.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 141 | 8.2% | 11.1% | 0.9 | 16 129 992 | 8.5% | 9.6% | 0.8 | -0.2% |
| BRAINMAX | 923 | -5.5% | 100.0% | 0 | 3 355 432 | -6.1% | 100.0% | 0 | -5.5% |
| GOLDLINE PLUS | 17 288 | 6.4% | 43.9% | 0 | 55 329 098 | 7.6% | 35.8% | -0.1 | 6.5% |
| MIGRENIUM | 13 627 | 3.8% | 0.6% | 0 | 3 944 889 | 7.3% | 0.7% | 0.1 | -2.6% |
| MODELAX-N | 31 087 | 2.0% | 22.7% | 0 | 12 789 953 | 4.3% | 14.1% | 0.4 | 1.9% |
| REDUXIN CAPS | 13 045 | 8.4% | 33.1% | 0.6 | 71 245 323 | 9.3% | 46.1% | 0.6 | 6.5% |
| REDUXIN FORTE | 3 683 | 6.1% | 9.3% | 0 | 16 651 803 | 5.1% | 10.8% | -0.3 | 6.5% |
| SALVISAR | 8 789 | 3.9% | 1.1% | 0 | 3 299 513 | 8.0% | 1.0% | 0 | 2.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 26 944 | -13.8% | 11.2% | 1.1 | 60 190 108 | -9.5% | 9.7% | 1.2 | -22.4% |
| BRAINMAX | 4 282 | -21.7% | 100.0% | 0 | 15 184 484 | -21.8% | 100.0% | 0 | -21.7% |
| GOLDLINE PLUS | 67 010 | 7.4% | 43.5% | -2.3 | 219 972 521 | 8.7% | 36.1% | -3.2 | 13.2% |
| MIGRENIUM | 49 774 | 6.2% | 0.5% | 0.1 | 13 094 535 | 21.4% | 0.6% | 0.2 | -12.8% |
| MODELAX-N | 119 582 | 21.1% | 20.1% | 3.9 | 47 270 565 | 27.9% | 12.0% | 2.8 | -2.4% |
| REDUXIN CAPS | 52 526 | 24.8% | 34.1% | 3.2 | 284 702 122 | 30.8% | 46.8% | 4.5 | 13.2% |
| REDUXIN FORTE | 12 983 | 5.2% | 8.4% | -0.6 | 56 969 472 | 5.2% | 9.4% | -1.2 | 13.2% |
| SALVISAR | 33 814 | -10.9% | 1.0% | 0 | 11 736 943 | -6.1% | 0.8% | 0 | -10.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs